remibrutinib
novartis
['remibrutinib']
pike m abstract 1113. remibrutinib (lou064) in sj gren s syndrome: safety and efficacy results from a 24 week placebo-controlled proof-of-concept study #acrbest #acr22 
MD PhD Consultant Rheumatologist &Physician,Assoc Medical Director,Digital Leader,NASS Trustee &Best Rheum Care,Visiting Fellow Henley Business School,ExecCoach